Features | Partner Sites | Information | LinkXpress
Sign In
BioConferenceLive
JIB
GLOBETECH PUBLISHING

New Benchtop Centrifuge Provides High-Throughput, Enhances Lab Productivity

By BiotechDaily International staff writers
Posted on 24 Sep 2013
Image: The Allegra X-5 benchtop centrifuge, from Beckman Coulter Life Sciences, automates clinical sample processing (Photo courtesy of Beckman Coulter).
Image: The Allegra X-5 benchtop centrifuge, from Beckman Coulter Life Sciences, automates clinical sample processing (Photo courtesy of Beckman Coulter).
A new benchtop centrifuge has been specially designed to handle higher sample numbers as well as more exacting conditions, such as those required for clinical sample preparation.

As the latest member of the energy-efficient Allegra suite of benchtop centrifuges, the Allegra X-5 air-cooled benchtop centrifuge from Beckman Coulter Life Sciences, of Beckman Coulter, Inc. (Brea, CA, USA), offers the performance, reliability, and endurance under exacting circumstances for which these products are designed.

Beckman Coulter UniCel DxC and UniCel DxI sample racks can be spun directly in the centrifuge, eliminating transfer steps. Easy-to-order bundled packages, which include swinging bucket rotors and common adapters, enable fast and convenient setup, are offered for a range of sample prep applications. Throughput and productivity can be further enhanced through seamless integration with the Beckman Coulter Automate 2500 family of sample processing systems.

A small footprint allows the unit to fit comfortably on the benchtop, while still providing capacity for up to 140 tubes. Maximum speed of 4,700 rpm and centrifugal force of up to 4,470 x g shortens run times.

“Reliability in demanding conditions makes the Allegra X-5 a smart addition to the clinical [or similar high-throughput] laboratory,” said David Rolwing, centrifuge product manager, Beckman Coulter Life Sciences. Benchtop centrifuges in the Allegra suite are offered for such clinical, clinical research, and other sample preparation applications as serum, plasma, and whole blood sample processing; protein precipitation, and particulate and cell sedimentation; in vitro cytotoxicity and receptor binding sample processing; and more.

Related Links:

Beckman Coulter




comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Microcomputed tomography images (top) and histology images (bottom) of the knees of mice fed a very high fat diet containing omega-3 fatty acid supplement (left) or only omega-6 fatty acids (right) after a knee injury. The omega-6 diet showed abnormal bone remodeling and calcified tissue formation in the joint (white arrow). The omega-6 diet also showed significant loss of cartilage (red staining, yellow arrowhead) and increased joint inflammation (Photo courtesy of Duke University).

Dietary Omega-3 Fatty Acids Moderate Severity of Osteoarthritis in a Mouse Model

Researchers working with an osteoarthritis (OA) obese mouse model found that the fat content of the animals' diet contributed more to the development or arrest of OA than did body weight.... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel

Vaccine Being Developed for Heart Disease Close to Reality

The world’s first vaccine for heart disease is becoming a possibility with researchers demonstrating significant arterial plaque reduction in concept testing in mice. Klaus Ley, MD, from the La Jolla Institute for Allergy and Immunology (LA Jolla, CA, USA), and a vascular immunology specialist, is leading the vaccine... Read more

Business

view channel

A Surge in IPOs Revitalize Investments for the Global Pharma and Biotech

Anti-infective drugs, oncology, and pharmaceutical contract laboratories attract the most investment up to now. The intensified private equity and venture capital (PEVC) deal activity in the global healthcare industry during the recession years, 2008–2010, witnessed a waning post-2010. However, the decline in deals... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.